U.S. Physical Therapy (NYSE:USPH) Announces Earnings Results

U.S. Physical Therapy (NYSE:USPH - Get Free Report) posted its earnings results on Wednesday. The company reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04), Zacks reports. The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%.

U.S. Physical Therapy Trading Down 1.6 %

Shares of NYSE:USPH traded down $1.34 during trading on Friday, reaching $81.08. 247,964 shares of the company traded hands, compared to its average volume of 101,014. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The business's fifty day moving average is $88.20 and its 200-day moving average is $87.60. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of 86.26, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.22%. U.S. Physical Therapy's payout ratio is currently 95.65%.

Wall Street Analysts Forecast Growth

USPH has been the subject of several recent analyst reports. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 target price for the company. StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday. Citizens Jmp upgraded U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Tuesday, December 3rd. Finally, William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of "Moderate Buy" and an average price target of $111.50.

Remove Ads

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.70% of the stock is currently owned by company insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.